Wang, X.; Zhang, L.; Dai, Q.; Si, H.; Zhang, L.; Eltom, S.E.; Si, H.
Combined Luteolin and Indole-3-Carbinol Synergistically Constrains ERα-Positive Breast Cancer by Dual Inhibiting Estrogen Receptor Alpha and Cyclin-Dependent Kinase 4/6 Pathway in Cultured Cells and Xenograft Mice. Cancers 2021, 13, 2116.
https://doi.org/10.3390/cancers13092116
AMA Style
Wang X, Zhang L, Dai Q, Si H, Zhang L, Eltom SE, Si H.
Combined Luteolin and Indole-3-Carbinol Synergistically Constrains ERα-Positive Breast Cancer by Dual Inhibiting Estrogen Receptor Alpha and Cyclin-Dependent Kinase 4/6 Pathway in Cultured Cells and Xenograft Mice. Cancers. 2021; 13(9):2116.
https://doi.org/10.3390/cancers13092116
Chicago/Turabian Style
Wang, Xiaoyong, Lijuan Zhang, Qi Dai, Hongzong Si, Longyun Zhang, Sakina E. Eltom, and Hongwei Si.
2021. "Combined Luteolin and Indole-3-Carbinol Synergistically Constrains ERα-Positive Breast Cancer by Dual Inhibiting Estrogen Receptor Alpha and Cyclin-Dependent Kinase 4/6 Pathway in Cultured Cells and Xenograft Mice" Cancers 13, no. 9: 2116.
https://doi.org/10.3390/cancers13092116
APA Style
Wang, X., Zhang, L., Dai, Q., Si, H., Zhang, L., Eltom, S. E., & Si, H.
(2021). Combined Luteolin and Indole-3-Carbinol Synergistically Constrains ERα-Positive Breast Cancer by Dual Inhibiting Estrogen Receptor Alpha and Cyclin-Dependent Kinase 4/6 Pathway in Cultured Cells and Xenograft Mice. Cancers, 13(9), 2116.
https://doi.org/10.3390/cancers13092116